dalteparin has been researched along with Ductus Arteriosus, Patent in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Ductus Arteriosus, Patent: A congenital heart defect characterized by the persistent opening of fetal DUCTUS ARTERIOSUS that connects the PULMONARY ARTERY to the descending aorta (AORTA, DESCENDING) allowing unoxygenated blood to bypass the lung and flow to the PLACENTA. Normally, the ductus is closed shortly after birth.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Blanche, LE | 1 |
| Schmitz, ML | 1 |
| Johnson, CE | 1 |
| Best, TH | 1 |
| Drummond-Webb, JJ | 1 |
1 review available for dalteparin and Ductus Arteriosus, Patent
| Article | Year |
|---|---|
Successful surgical management of a neonate with a saddle pulmonary embolus.
Topics: Anticoagulants; Arm; Cardiopulmonary Bypass; Ductus Arteriosus, Patent; Embolectomy; Enoxaparin; Fem | 2004 |